Thermo Fisher Details Shareholder Dissent on Executive Pay, Announces 2026 Compensation Program Changes and CEO Retention Grant
summarizeSummary
Thermo Fisher Scientific disclosed that its 2025 executive compensation proposal received only 36% shareholder support, leading to significant changes in the 2026 long-term incentive program and a one-time $57.7 million CEO retention grant.
check_boxKey Events
-
Shareholder Say-on-Pay Dissent
The 2025 advisory vote on executive compensation received only 36% shareholder support, signaling significant investor dissatisfaction with current pay practices.
-
2026 Compensation Program Overhaul
In response to shareholder feedback, the company revised its 2026 long-term incentive program to include 3-year performance metrics, increased weighting for relative TSR and ROIC, and a commitment to limit one-time equity grants.
-
CEO Retention Grant Approved
A one-time performance-based restricted stock unit award valued at $57.7 million was approved for CEO Marc N. Casper in May 2025, with cliff vesting in 2030 and deferred share delivery until 2033-2035, contingent on TSR performance.
-
Board Composition Change
Director James C. Mullen is not standing for re-election, which will reduce the board size from 12 to 11 members effective at the 2026 Annual Meeting.
auto_awesomeAnalysis
This DEF 14A filing reveals that Thermo Fisher Scientific's 2025 "say-on-pay" executive compensation proposal received only 36% shareholder support, indicating significant investor dissatisfaction. In response, the Compensation Committee has implemented material changes to the 2026 long-term incentive program, including shifting to 3-year performance metrics, increasing the weighting of relative Total Shareholder Return (TSR) and Return on Invested Capital (ROIC), and committing to fewer one-time equity grants. Concurrently, the Board approved a one-time $57.7 million performance-based restricted stock unit award for CEO Marc N. Casper in May 2025, designed for retention through 2030 with deferred share delivery until 2033-2035, contingent on TSR performance. This filing highlights a notable shift in executive compensation strategy driven by direct shareholder feedback.
At the time of this filing, TMO was trading at $488.25 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $181.4B. The 52-week trading range was $385.46 to $643.99. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.